English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2303]
News [5278]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
'Cellular barcoding' reveals how breast cancer spreads
'Cellular barcoding' reveals how breast cancer spreads
Researchers discover a weakness in a rare cancer that could be exploited with drugs
Researchers discover a weakness in a rare cancer that could be exploited with drugs
Immune stimulant molecule shown to prevent cancer
Immune stimulant molecule shown to prevent cancer
ASCO GU 2019: Preliminary results from a phase II GALAHAD study in adults with metastatic castration-resistant prostate cancer and DNA repair pathway defects
ASCO GU 2019: Preliminary results from a phase II GALAHAD study in adults with metastatic castration-resistant...
New research findings could be key to improving outcomes for some brain cancers
New research findings could be key to improving outcomes for some brain cancers
Platelet 'decoys' outsmart both clots and cancer
Platelet 'decoys' outsmart both clots and cancer
New therapeutic target found for aggressive paediatric cancers with few treatment options
New therapeutic target found for aggressive paediatric cancers with few treatment options
Scientists find a way to stop the immortality of cancer cells with oligonucleotides
Scientists find a way to stop the immortality of cancer cells with oligonucleotides
ASCO GU 2019: Pembrolizumab plus axitinib extended overall survival and progression-free survival versus current standard treatment for advanced kidney cancer
ASCO GU 2019: Pembrolizumab plus axitinib extended overall survival and progression-free survival versus current...
ASCO GU 2019: Phase II trial shows novel, radiolabelled PSMA-targeted treatment provides high response rates in men with metastatic prostate cancer
ASCO GU 2019: Phase II trial shows novel, radiolabelled PSMA-targeted treatment provides high response rates in...
<1...280281282283284...528>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top